End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,505 KRW | +3.44% |
|
+3.68% | +2.39% |
Business Summary
Sales per Business
KRW in Million | 2023 | Weight | Delta |
---|---|---|---|
Daily Medicine
100.0
%
| 3,461 | 100.0 % | - |
Sales per region
KRW in Million | 2023 | Weight | Delta |
---|---|---|---|
South Korea
100.0
%
| 3,461 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Duk-Hoon Hyun
CEO | Chief Executive Officer | - | - |
Yeong-Su Im
DFI | Director of Finance/CFO | 61 | 19-09-30 |
U-Seok Go
BRD | Director/Board Member | 59 | 20-02-29 |
Tae-Won Ban
BRD | Director/Board Member | 50 | 18-12-31 |
Jae-Yeong Yang
BRD | Director/Board Member | 60 | 18-12-31 |
Cheong-Seok Seo
AUD | Comptroller/Controller/Auditor | 79 | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jae-Yeong Yang
BRD | Director/Board Member | 60 | 18-12-31 |
Tae-Won Ban
BRD | Director/Board Member | 50 | 18-12-31 |
U-Seok Go
BRD | Director/Board Member | 59 | 20-02-29 |
Yeong-Jun Kim
BRD | Director/Board Member | 62 | 19-02-28 |
Dae-Hyeon Shin
BRD | Director/Board Member | 41 | 19-01-13 |
Hyeon-Cheol Dong
BRD | Director/Board Member | 63 | 19-07-31 |
Yeong-Wuk An
BRD | Director/Board Member | 69 | 00-02-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 61,501,469 | 27,455,992 ( 44.64 %) | 0 | 44.64 % |
Company contact information
Prestige Biologics Co., Ltd.
197, Osongsaengmyeong 1-ro Osong-eup
28161, Cheongju-si
+
http://www.pbpharma.co.kr![address Prestige Biologics Co., Ltd.(A334970)](https://cdn.zonebourse.com/static/address/120977000.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+2.39% | 200M | |
+7.46% | 100B | |
+8.42% | 42.34B | |
-13.04% | 32.76B | |
+80.35% | 29.46B | |
-10.92% | 16.31B | |
+1.93% | 14.39B | |
-6.77% | 12.23B | |
+177.16% | 10.47B | |
+2.10% | 8.97B |
- Stock Market
- Equities
- A334970 Stock
- Company Prestige Biologics Co., Ltd.